The COCOON trial regimen reduced dermatologic side effects in patients with EGFR-mutant non-small cell lung cancer, phase 2 ...

New study results presented at the European Lung Cancer Congress (ELCC) 2025, March 26 to 29, demonstrate the role of AstraZeneca's TAGRISSO® (osimertinib), as monotherapy and as the backbone for ...

6 The eGFR blood test may not provide accurate results in patients with unstable creatinine concentrations, including pregnant women, hospitalized patients with acute kidney injury, cancer ...

The first-line combination of amivantamab-vmjw plus lazertinib extended OS compared with osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer, according to data from the ...

Oral semaglutide reduced risk for major adverse CV events by 14% in high-risk adults with type 2 diabetes regardless of SGLT2 ...

women should not breastfeed during treatment with TAGRISSO and for 2 weeks after the last dose While EGFR-TKIs have significantly improved outcomes in the 1st-line setting, mechanisms of ...

Patients with lung adenocarcinoma typically carry a mutation in the Epidermal Growth Factor Receptor (EGFR) gene, making them ...

It came out of nowhere for Elizabeth Williams. Life-changing news started with what seemed like a simple cough.

Injectable semaglutide has better bioavailability, researchers say, but the many patients who want an oral drug are an unmet ...

CHICAGO -- For people with heart failure (HF), the long-presumed benefits of fluid restriction did not pan out in the ...